Alnylam CEO on what is next for heart disease drug

CNBC's Angelica Peebles and Yvonne Greenstreet, Alnylam CEO, joins 'Fast Money' to talk the companies latest heart condition drug data and what the path to approval looks like.

Jun 25, 2024 - 10:00

0 4

Alnylam CEO on what is next for heart disease drug

CNBC's Angelica Peebles and Yvonne Greenstreet, Alnylam CEO, joins 'Fast Money' to talk the companies latest heart condition drug data and what the path to approval looks like.

Tags:

Previous Article

Housing in pandemic boom towns up to 40% overvalued, says Reventure CEO Nick Gerli

Recursion CEO Chris Gibson talks integrating AI into drug development process

admin

admin

This website uses cookies to enhance your browsing experience. By continuing to use this site, you consent to the use of cookies. Please review our Privacy Policy for more information on how we handle your data.